GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Revenue

Daito Pharmaceutical Co (TSE:4577) Revenue : 円47,369 Mil (TTM As of Nov. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Revenue?

Daito Pharmaceutical Co's revenue for the three months ended in Nov. 2024 was 円11,906 Mil. Its revenue for the trailing twelve months (TTM) ended in Nov. 2024 was 円47,369 Mil. Daito Pharmaceutical Co's Revenue per Share for the three months ended in Nov. 2024 was 円778.53. Its Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2024 was 円3,071.20.

Warning Sign:

Daito Pharmaceutical Co Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Daito Pharmaceutical Co was 5.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -2.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was -1.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Daito Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 4.90% per year. The lowest was -5.40% per year. And the median was 1.30% per year.


Daito Pharmaceutical Co Revenue Historical Data

The historical data trend for Daito Pharmaceutical Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Revenue Chart

Daito Pharmaceutical Co Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44,997.11 48,709.00 43,464.00 45,101.00 46,895.00

Daito Pharmaceutical Co Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,932.00 10,552.00 12,233.00 12,678.00 11,906.00

Competitive Comparison of Daito Pharmaceutical Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daito Pharmaceutical Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's Revenue distribution charts can be found below:

* The bar in red indicates where Daito Pharmaceutical Co's Revenue falls into.


;
;

Daito Pharmaceutical Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円47,369 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daito Pharmaceutical Co  (TSE:4577) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Daito Pharmaceutical Co Revenue Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Daito Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co Headlines

No Headlines